Stock ANTX AN2 THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Real-time Estimate Cboe BZX
Other stock markets
 02:18:17 2024-06-10 pm EDT 		5-day change 1st Jan Change
1.955 USD -3.69% Intraday chart for AN2 Therapeutics, Inc. -7.14% -90.48%
May. 16 Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating MT
May. 14 AN2 Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating
MT
JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform
MT
Leerink Partners Downgrades AN2 Therapeutics to Market Perform From Outperform, Adjusts PT to $7 From $23
MT
Oppenheimer Downgrades AN2 Therapeutics to Market Perform From Outperform
MT
Evercore ISI Downgrades AN2 Therapeutics to In Line from Outperform, Adjusts PT to $7 From $25
MT
JMP Securities Downgrades AN2 Therapeutics to Market Perform From Market Outperform
MT
JMP Securities Initiates AN2 Therapeutics With Market Outperform Rating, Price Target is $30
MT
Oppenheimer Adjusts AN2 Therapeutics Price Target to $27 From $24, Maintains Outperform Rating
MT
Oppenheimer Adjusts AN2 Therapeutics Price Target to $24 From $20, Maintains Outperform Rating
MT
Oppenheimer Adjusts AN2 Therapeutics Price Target to $20 From $22, Maintains Outperform Rating
MT
Evercore ISI Initiates Coverage on AN2 Therapeutics With Outperform Rating, $25 Price Target
MT
Oppenheimer Initiates Coverage on AN2 Therapeutics With Outperform Rating, $22 Price Target
MT
Cowen Starts AN2 Therapeutics at Outperform
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANTX Stock
  4. News AN2 Therapeutics, Inc.
  5. Analyst Reco.